Antepartum continuous epidural ropivacaine therapy reduces uterine artery vascular resistance in pre-eclampsia: A randomized, dose-ranging, placebo-controlled study

Y. Ginosar*, M. Nadjari, A. Hoffman, N. Firman, E. M. Davidson, C. F. Weiniger, L. Rosen, C. Weissman, U. Elchalal, A. Avidan, Y. Golob, E. Y. Anteby, Y. Ezra, D. Hochner-Celnikier, D. D. Mankuta, S. Yagel, L. Kleinberg, S. Haroutinian, B. Bar-Oz, H. KanielN. Novick, S. H. Halpern

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Antepartum continuous epidural ropivacaine therapy reduces uterine artery vascular resistance in pre-eclampsia: A randomized, dose-ranging, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences